A detailed history of Norwood Financial Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Norwood Financial Corp holds 7,145 shares of ABT stock, worth $816,173. This represents 1.18% of its overall portfolio holdings.

Number of Shares
7,145
Previous 7,145 -0.0%
Holding current value
$816,173
Previous $786,000 3.31%
% of portfolio
1.18%
Previous 1.2%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 11, 2024

SELL
$90.19 - $110.4 $8,928 - $10,929
-99 Reduced 1.37%
7,145 $786,000
Q3 2023

Oct 16, 2023

SELL
$95.53 - $114.62 $21,016 - $25,216
-220 Reduced 2.95%
7,244 $701,000
Q2 2023

Jul 27, 2023

SELL
$100.78 - $112.29 $10,178 - $11,341
-101 Reduced 1.34%
7,464 $813,000
Q4 2021

Feb 08, 2022

BUY
$115.53 - $141.46 $873,984 - $1.07 Million
7,565 New
7,565 $1.06 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Norwood Financial Corp Portfolio

Follow Norwood Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norwood Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Norwood Financial Corp with notifications on news.